Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Merle

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Therapie|September 1, 2005
[Comparison of reports from patients and health professionals: statins and muscle disorders]Marie-Laure Laroche, Louis Merle
Lancet (London, England)|August 4, 2004
Statins for multiple sclerosisMarie-Laure Laroche, Louis Merle
Annals of Internal Medicine|December 7, 2005
Generic drug savingsMarie-Laure Laroche, Louis Merle
Pharmacoepidemiology and Drug Safety|February 19, 2016
Quality of serious adverse events reporting to academic sponsors of clinical trials: far from optimalSabrina Crépin, Claire Villeneuve, Louis Merle
Therapie|October 22, 2008
Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reportingVéronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|July 10, 2016
[Not Available]Véronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Lancet (London, England)|October 2, 2007
Prescribing in elderly peopleMarie-Laure Laroche, Jean-Pierre Charmes, Louis Merle
European Journal of Clinical Pharmacology|June 8, 2007
Potentially inappropriate medications in the elderly: a French consensus panel listMarie-Laure Laroche, Jean-Pierre Charmes, Louis Merle
Journal of Inorganic Biochemistry|March 7, 2003
Inhibition of human serum arylesterase by metal chloridesJean Debord, Jean-Claude Bollinger, Louis Merle, et al.
The Annals of Pharmacotherapy|November 5, 2014
Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance databaseMarie-Laure Laroche, Isabelle Quelven, Joachim Mazère, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Therapie|September 1, 2005
[Comparison of reports from patients and health professionals: statins and muscle disorders]Marie-Laure Laroche, Louis Merle
Lancet (London, England)|August 4, 2004
Statins for multiple sclerosisMarie-Laure Laroche, Louis Merle
Annals of Internal Medicine|December 7, 2005
Generic drug savingsMarie-Laure Laroche, Louis Merle
Pharmacoepidemiology and Drug Safety|February 19, 2016
Quality of serious adverse events reporting to academic sponsors of clinical trials: far from optimalSabrina Crépin, Claire Villeneuve, Louis Merle
Therapie|October 22, 2008
Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reportingVéronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Therapie|July 10, 2016
[Not Available]Véronique Lamarque, Louis Merle, Jean Paul Demarez, et al.
Lancet (London, England)|October 2, 2007
Prescribing in elderly peopleMarie-Laure Laroche, Jean-Pierre Charmes, Louis Merle
European Journal of Clinical Pharmacology|June 8, 2007
Potentially inappropriate medications in the elderly: a French consensus panel listMarie-Laure Laroche, Jean-Pierre Charmes, Louis Merle
Journal of Inorganic Biochemistry|March 7, 2003
Inhibition of human serum arylesterase by metal chloridesJean Debord, Jean-Claude Bollinger, Louis Merle, et al.
The Annals of Pharmacotherapy|November 5, 2014
Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance databaseMarie-Laure Laroche, Isabelle Quelven, Joachim Mazère, et al.
Pageof 3